Troxacitabine in patients with refractory leukemia

J Clin Oncol. 2002 Aug 1;20(15):3356; author reply 3356-7. doi: 10.1200/JCO.2002.99.902.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Area Under Curve
  • Clinical Trials, Phase II as Topic
  • Cytosine / analogs & derivatives*
  • Cytosine / pharmacokinetics
  • Cytosine / therapeutic use*
  • Dioxolanes / pharmacokinetics
  • Dioxolanes / therapeutic use*
  • Humans
  • Leukemia / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Dioxolanes
  • troxacitabine
  • Cytosine